SS Innovations International (NASDAQ:SSII) Stock Jumps 8.8% - Here's Why

Key Points

• SS Innovations International shares rose 8.8% to about $2.56 in mid-day trading, although volume was 71% below the average session volume.
• Despite the stock jump, analyst sentiment remains negative: Weiss Ratings reaffirmed a “sell (e+)” rating, while the consensus rating is “Sell” with an average price target of $7.00.
• The company reported a quarterly loss of $0.01 per share, $13.94 million in revenue, and continued negative profitability metrics, including a 23.73% net margin and 26.77% return on equity.

SS Innovations International, Inc. (NASDAQ:SSII - Get Free Report)'s stock price traded up 8.8% during mid-day trading on Monday. The company traded as high as $2.51 and last traded at $2.5570. Approximately 19,758 shares were traded during trading, a decline of 71% from the average session volume of 69,319 shares. The stock had previously closed at $2.35.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a "sell (e+)" rating on shares of SS Innovations International in a research report on Thursday, October 15th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, SS Innovations International currently has a consensus rating of "Sell" and an average price target of $7.00.

SS Innovations International Trading Up 1.9%

The company has a market cap of $479.91 million, a price-to-earnings ratio of -39.18 and a beta of -1.51. The stock has a 50-day simple moving average of $2.96 and a 200-day simple moving average of $3.90.

SS Innovations International (NASDAQ:SSII - Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $13.94 million for the quarter. SS Innovations International had a negative net margin of 23.73% and a negative return on equity of 26.77%.

Insider Activity

In related news, CEO Srivastava Sudhir sold 33,333 shares of the firm's stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $3.00, for a total transaction of $99,999.00. Following the transaction, the chief executive officer owned 108,520,928 shares in the company, valued at $325,562,784. This trade represents a 0.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Institutional Trading of SS Innovations International

A hedge fund recently raised its position in SS Innovations International stock. Inspire Investing LLC boosted its position in shares of SS Innovations International, Inc. (NASDAQ:SSII - Free Report) by 19.7% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 223,053 shares of the company's stock after buying an additional 36,756 shares during the quarter. Inspire Investing LLC owned 0.11% of SS Innovations International worth $665,000 at the end of the most recent quarter.

SS Innovations International Company Profile

SS Innovations International, Inc is a medical technology company focused on developing and commercializing robotic-assisted surgical systems. Its principal product is the SSi Mantra surgical robotic system, which is designed to support surgeons in performing minimally invasive procedures across a range of specialties.

The company also develops related surgical instruments, accessories, and technology intended to complement the SSi Mantra platform. Its products are designed to help hospitals expand access to robotic-assisted surgery while supporting precision, visualization, and surgeon control during procedures.

SS Innovations was founded by Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.